Depression

Neuroinflammation may be a culprit in the development of psychosis. What are the clinical implications?

How do the 3 FDA-approved dopamine receptor partial agonists for the treatment of MDD and other psychiatric disorders stack up against each other?

A new finding that may help optimize the treatment of major depressive disorder.

Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.

Psychiatrists increasingly recognize that not all treatments for depression are created equal-but in this case, an entirely different diagnosis came to light.

The challenges in providing mental health care to the college community are significant. Here's a brief look at the issues.

The author scrutinizes the results of a new pilot study that finds the Fisher Wallace Stimulator® effective in treating bipolar depression.

This article summarizes clinically relevant advances in the psychiatric care of women during and after pregnancy, including recent changes in how the FDA classifies pregnancy risk for medications, and best practices in perinatal psychopharmacology.

Researchers conducted a clinical trial comparing light therapy with antidepressant monotherapy. Here's what they found.

There is no one-size-fits-all solution to how people and cultures should respond to overwhelming stress, depression, and trauma.

Although college students are in many ways similar to any patient in their age group, their environment and stressors differ in significant ways. The authors identify issues to consider in assessing and managing suicidality in this population.

Researchers looked into the efficacy and value of TMS for treatment-resistant depression.

If serotonin was once American psychiatry’s “high school crush,” the field now appears wedded to a more mature model of biological and psychosocial understanding.

Comorbid medical symptoms, polypharmacy, and cognitive decline are hallmarks of depression in the fastest growing segment of the population.

An update on what happens in the brain when the mind is engaged in psychotherapy.

In the treatment of depression, clinicians are often faulted for failing to give an antidepressant medication at a high enough dose. What is high enough? Answering this question turns out to be tricky.

Food taken with which atypical antipsychotics discussed here may increase absorption?

Striking findings on the relationship between stress and depression.

Twenty years ago, it was rare for college students to mention suicidal thoughts, and even more rare to involve parents in their care. Today, students are more likely to describe suicidal ideation, necessitating a more thorough safety assessment with potential outreach to parents.

Experts summarize data on the role of inflammation in psychiatric disorders, emphasizing that evidence for anti-inflammatory treatment for mood disorders is limited, and mixed.

Impulsivity has long been thought to be an important risk factor for depression and suicide. But recent research suggests that the reality might actually be counterintuitive.

Recent studies find powerful biological changes associated with mind-body interventions comparable to those associated with conventional antidepressants or psychotherapies.

Over the past 10 years, a growing literature has documented the significantly increased rates of stress, burnout, depression, and suicidal ideation in medical students.

Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations-usually in under 2 minutes.

Circadian components are profound in depressive disorders, such seasonal affective disorder. This article introduces a course to be given at this year’s APA Meeting in Toronto, on melatonin and light treatment.